Table of Contents Table of Contents
Previous Page  559 / 812 Next Page
Information
Show Menu
Previous Page 559 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

S555

Positive and Negative Syndrome Scale (PANSS); Global Assessment

of Functioning (GAF); Clinical Global Impression (CGI); designed

extensive questionnaire to elicit demographic data; inquiry about

drug compliance and Victimization Questionnaire.

Results

Seventy patients of the studied sample were non-

victimized and 30 patients were victimized. Victimized patients

were significantly younger, living mainly in urban areas, had less

frequent history of bullying at school. There were exposed sig-

nificantly to higher frequency of family domestic violence and

childhood abuse. They scored higher for all subscales and in total

PANSS scores and they were less compliant on medication than did

their non-victimized counterparts.

Conclusion

Studies of victimization of mentally ill did not draw

the attention of researchers and clinicians in Arab world. This study

proves that victimization is not uncommon among patients with

schizophrenia; clinicians should include assessment for victimiza-

tion of their patients as a routine work. The current study provides

preliminary data for clinicians and policymakers to consider strate-

gies to protect patients with various mental illnesses from being

victimized.

Disclosure of interest

The author has not supplied his declaration

of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1627

EV643

Study of self-perceived health in a

clinical sample

A. Fernandez-Quintana

, M.D.C. García-Mahía

Clinical University Hospital of La Coru˜na, Psychiatry, La Coru˜na,

Spain

Corresponding author.

Introduction

The assessment of self-perceived health provides an

insightful clinical tool when it comes to addressing the subjective

perception of social functioning, mental and physical health.

Objective

To analyze self-perceived health in patients treated in

a primary care clinic and its relationship with other clinical and

socio-demographic variables.

Methods

A randomized sample of 130 patients, aged 18 years or

over, undergoing treatment in a primary care clinic was evaluated.

Patientswere interviewed following a self-perceivedhealth scale as

well as a scale for other clinical and socio-demographic variables.

Clinical records were reviewed for prior psychiatric and somatic

diagnoses.

Results

Overall, the prevalence of somatic disorders in our sim-

ple was 92.3%, whilst psychiatric disorders were present in 23% of

patients. Only 6% of the sample reported their mental health to be

affected to some degree, while 67% declared their physical health

to be damaged. Forty-three percent of the sample follows pre-

scribed psychopharmacological treatment. Women showed lower

self-perceived health and reported more psychiatric symptoms in

accordance with higher actual prevalences of psychiatric disorders.

Among those patients with a psychiatric illness, only two reported

the will to search for mental health care, whilst most would prefer

consulting their general practitioner.

Conclusions

Less than half of the patients who have been diag-

nosed with a psychiatric disorder consider their mental health to

be affected. Among those who do report a self-perceived mental

health concern, the majority would prefer consulting their general

practitioner rather than a psychiatrist.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1628

EV644

Motives and behaviors of medical

students (mis)using prescription

stimulants

G. Fond

1

, F. Berna

2 ,

, P. Domenech

3 , 4

1

Schizophrenia Expert Center Fondation Fondamental, Creteil, France

2

Hôpitaux Universitaires de Strasbourg, Inserm U1114, FMTS,

Fondation FondaMental, Psychiatry, Strasbourg cedex, France

3

Inserm U955, Translational Psychiatry team, Créteil, France

4

Paris Est University, DHU Pe-PSY, Pôle de Psychiatrie des Hôpitaux

Universitaires H.-Mondor & Spine Institute, CRICM, UPMC, Inserm

UMR S 975, CNRS UMR 7225, CHU Pitié-Salpêtrière, Brain & Spine

Institute, CRICM, UPMC, Inserm UMR S 975, CNRS UMR 7225, CHU

Pitié-Salpêtrière, Créteil, France

Corresponding author.

Aims

To estimate the prevalence of psychostimulant use in

French medical undergraduate and postgraduate students, asso-

ciated consumption behaviors and motives.

Design

A population-based cross-sectional study using a self-

administered online survey.

Participants

A total of 1718 French students and physicians

(mean age 26.84

±

7.19 years, 37.1% male).

Measurements

Self-reported lifetime use, motives, socio-

demographic and academic features for other the counter (OTC),

medically prescribed (MPP), and Illicit (IP) psychostimulant users.

Findings

Lifetime prevalence of psychostimulant use was 33%

(29.7% for OTC, 6.7% for MPP and 5.2% for IP). OTC con-

sumption mainly aimed at increasing wakefulness during com-

petitive exams preparation and internship. OTC consumption

was twice more frequent among users of other psychostim-

ulants (MPP and/or IP). Most of OTC consumers began their

consumption during exam preparation. Corticoids were the

most frequently consumed MPP (4.5%) before methylphenidate

and modafinil (1.5% and 0.8%, respectively). Unlike corticoids,

methylphenidate and modafinil prescriptions are tightly regulated

in France. Motives for MPP consumption were increased aca-

demic performance/concentration–memory and wakefulness. In

that respect, restrictions on methylphenidate and modafinil pre-

scriptions seem to be effective at limiting misuse. Corticoids were

mostly consumed by interns seeking for wakefulness. Overall, 5.2%

of the subjects consumed at least once IP, mostly cocaine and

amphetamine derivatives. They sought euphoria and/or novelty.

Conclusions

Psychostimulant use is common among French

undergraduate students, interns and postgraduate physicians. The

type of drug used seems to depend mainly on product avail-

ability. Increased rates of corticoids consumption for wakefulness

purposes suggest another potential public health problem, as cor-

ticoids may have severe side effects.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1629

EV645

The assessment of social disability in

persons with a diagnosis of mental

disorder. Preliminary data

T.M. Gondek

, A. Królicka , B. Misiak , A. Kiejna

Wroclaw Medical University, Department of Psychiatry, Wroclaw,

Poland

Corresponding author.

Social disability in persons diagnosed with mental disorder is

one of the factors preventing them from achieving the broadly

definedwell-being, evenwhen appropriate and effective treatment

is applied. Improvement in the field of social disability is therefore

one of the main challenges for the mental health and social welfare